Intraoperative loading of calcium phosphate-coated implants with gentamicin prevents experimental Staphylococcus aureus infection in vivo.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2019
Historique:
received: 11 10 2018
accepted: 21 12 2018
entrez: 2 2 2019
pubmed: 2 2 2019
medline: 30 10 2019
Statut: epublish

Résumé

Orthopedic device-related infection (ODRI) is a potentially devastating complication arising from the colonization of the device with bacteria, such as Staphylococcus aureus. The aim of this study was to determine if intraoperative loading of a clinically approved calcium phosphate (CaP) coating with gentamicin can protect from ODRI in vivo. First, CaP-coated titanium aluminium niobium (TAN) discs were used to investigate the adsorption and release kinetics of gentamicin in vitro. Gentamicin loading and subsequent release from the coating were both rapid, with maximum loading occurring following one second of immersion, and >95% gentamicin released within 15 min in aqueous solution, respectively. Second, efficacy of the gentamicin-loaded CaP coating for preventing ODRI in vivo was investigated using a CaP-coated unicortical TAN screw implanted into the proximal tibia of skeletally mature female Wistar rats, following inoculation of the implant site with S. aureus. Gentamicin-loading prevented ODRI in 7/8 animals, whereas 9/9 of the non-gentamicin treated animals were infected after 7 days. In conclusion, gentamicin can be rapidly and simply loaded onto, and released from, CaP-based implant coatings, and this is an effective strategy for preventing peri-operative S. aureus-induced ODRI in vivo.

Identifiants

pubmed: 30707699
doi: 10.1371/journal.pone.0210402
pii: PONE-D-18-29564
pmc: PMC6358082
doi:

Substances chimiques

Alloys 0
Calcium Phosphates 0
Coated Materials, Biocompatible 0
Gentamicins 0
titanium aluminum alloy 0
Niobium 05175J654G
calcium phosphate 97Z1WI3NDX

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0210402

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

J Bone Jt Infect. 2016 Jul 19;1:34-41
pubmed: 28529851
J Clin Microbiol. 1979 Dec;10(6):885-9
pubmed: 521487
Int J Artif Organs. 2008 Sep;31(9):841-7
pubmed: 18924097
Injury. 2016 Jul;47(7):1427-34
pubmed: 27178769
J Arthroplasty. 1993 Apr;8(2):157-66
pubmed: 8386746
Clin Orthop Relat Res. 1984 Nov;(190):89-95
pubmed: 6488651
J Orthop Res. 2010 Aug;28(8):992-9
pubmed: 20162715
J Antimicrob Chemother. 2003 Mar;51(3):585-91
pubmed: 12615858
J Biomed Mater Res B Appl Biomater. 2011 Oct;99(1):14-20
pubmed: 21648067
Acta Biomater. 2016 Oct 1;43:185-194
pubmed: 27435965
J Biomed Mater Res B Appl Biomater. 2005 May;73(2):277-84
pubmed: 15674827
BMC Musculoskelet Disord. 2006 Feb 26;7:18
pubmed: 16504140
Drugs. 2006;66(8):1089-105
pubmed: 16789794
EFORT Open Rev. 2017 Mar 13;1(4):89-99
pubmed: 28461934
Bone. 2003 May;32(5):521-31
pubmed: 12753868
Injury. 2006 May;37 Suppl 2:S59-66
pubmed: 16651073
Biomaterials. 2004 Aug;25(18):4287-95
pubmed: 15046919
Int J Artif Organs. 2010 Sep;33(9):667-75
pubmed: 20890880
J Bone Jt Infect. 2016 Oct 1;1:59-64
pubmed: 28529855
JBJS Case Connect. 2018 Jan-Mar;8(1):e8
pubmed: 29443819
J Bone Joint Surg Br. 1991 Sep;73(5):732-40
pubmed: 1654335
J Biomed Mater Res B Appl Biomater. 2007 Apr;81(1):23-9
pubmed: 16924618
Clin Pharmacokinet. 1995 Jul;29(1):36-45
pubmed: 7586897
Acta Orthop Scand. 2003 Dec;74(6):644-51
pubmed: 14763692
J Bone Miner Res. 2017 May;32(5):985-990
pubmed: 27933662
J Control Release. 2004 Sep 14;99(1):127-37
pubmed: 15342186
J Arthroplasty. 2008 Aug;23(5):762-71
pubmed: 18534525
Biomaterials. 2006 Sep;27(26):4627-34
pubmed: 16712926
Biomed Res Int. 2015;2015:587857
pubmed: 26064928
J Orthop Traumatol. 2017 Jun;18(2):159-169
pubmed: 28155060
J Intern Med. 2014 Aug;276(2):111-9
pubmed: 24605880
Acta Biomater. 2011 Mar;7(3):1274-80
pubmed: 21081183
J Antimicrob Chemother. 2001 Jun;47(6):885-91
pubmed: 11389124
J Biomed Mater Res B Appl Biomater. 2007 Oct;83(1):9-15
pubmed: 17318821
Lancet. 1981 Apr 11;1(8224):795-6
pubmed: 6111670

Auteurs

Keith Thompson (K)

AO Research Institute Davos, Davos, Switzerland.

Stoyan Petkov (S)

AO Research Institute Davos, Davos, Switzerland.
Spital Emmental, Burgdorf, Switzerland.

Stephan Zeiter (S)

AO Research Institute Davos, Davos, Switzerland.

Christoph M Sprecher (CM)

AO Research Institute Davos, Davos, Switzerland.

R Geoff Richards (RG)

AO Research Institute Davos, Davos, Switzerland.

T Fintan Moriarty (TF)

AO Research Institute Davos, Davos, Switzerland.

Henk Eijer (H)

Spital Emmental, Burgdorf, Switzerland.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH